Abstract
Phytochemicals are becoming more and more interesting in the field of therapeutic research, mainly in the treatment of chronic illnesses, due to the fact that many synthetic drugs cause important side effects that impact on pa- tient’s life quality. Pentacyclic triterpenes are a class of compounds with several therapeutic effects and increasing impor- tance in cancer therapy; however, a major disadvantage is their low water solubility and bioavailability which leads to rather poor therapeutic results in vivo.Technological attempts to improve the pharmacokinetic profile of the main repre- sentatives of this class include the use of cyclodextrins, micro- and nanoemulsions, liposomes, polymeric nanoparticles, and nanocapsules. This paper is aimed to briefly summarize the most significant achievements in this field.
Keywords: Bioavailability, cyclodextrin, liposome, nanoparticle, solubility, triterpenes.
Protein & Peptide Letters
Title:New Improved Drug Delivery Technologies for Pentacyclic Triterpenes: A Review
Volume: 21 Issue: 11
Author(s): Codruta Soica, Cristina Trandafirescu, Corina Danciu, Danina Muntean, Cristina Dehelean and Georgeta Simu
Affiliation:
Keywords: Bioavailability, cyclodextrin, liposome, nanoparticle, solubility, triterpenes.
Abstract: Phytochemicals are becoming more and more interesting in the field of therapeutic research, mainly in the treatment of chronic illnesses, due to the fact that many synthetic drugs cause important side effects that impact on pa- tient’s life quality. Pentacyclic triterpenes are a class of compounds with several therapeutic effects and increasing impor- tance in cancer therapy; however, a major disadvantage is their low water solubility and bioavailability which leads to rather poor therapeutic results in vivo.Technological attempts to improve the pharmacokinetic profile of the main repre- sentatives of this class include the use of cyclodextrins, micro- and nanoemulsions, liposomes, polymeric nanoparticles, and nanocapsules. This paper is aimed to briefly summarize the most significant achievements in this field.
Export Options
About this article
Cite this article as:
Soica Codruta, Trandafirescu Cristina, Danciu Corina, Muntean Danina, Dehelean Cristina and Simu Georgeta, New Improved Drug Delivery Technologies for Pentacyclic Triterpenes: A Review, Protein & Peptide Letters 2014; 21 (11) . https://dx.doi.org/10.2174/0929866521666140807115109
DOI https://dx.doi.org/10.2174/0929866521666140807115109 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy
Current Gene Therapy Metabolic Aspects of Prion Diseases: An Overview
Current Drug Targets SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Current Neuropharmacology TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
Current Drug Targets Is alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Current Alzheimer Research Recent Development of Peptide Drugs and Advance on Theory and Methodology of Peptide Inhibitor Design
Medicinal Chemistry Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer’s Disease
Current Alzheimer Research Acetylenic Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Cytostatic Properties of Some Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type I Receptor Antagonists
Current Pharmaceutical Design Endocannabinoids: A New Family of Lipid Mediators Involved in the Regulation of Neural Cell Development
Current Pharmaceutical Design Electrochemical DNA Biosensors in Drug Analysis
Current Pharmaceutical Analysis The Orvinols and Related Opioids - High Affinity Ligands with Diverse Efficacy Profiles
Current Pharmaceutical Design Classification of Sarcomas Using Bioinformatics and Molecular Profiling
Current Pharmaceutical Biotechnology Current Progress in Sample Preparation for Two-Dimensional Electrophoresis in Proteomics
Current Proteomics Microwave-Assisted Domino Cyclization Reactions
Current Microwave Chemistry Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses
Current Cancer Drug Targets Implication of Complement System and its Regulators in Alzheimers Disease
Current Neuropharmacology The Impact of Proteomics in the Understanding of the Molecular Basis of Paclitaxel-Resistance in Ovarian Tumors
Current Cancer Drug Targets The Neurophysiology of Hydrogen Sulfide
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacology of Sigma (σ) Receptor Ligands from a Behavioral Perspective
Current Pharmaceutical Design